This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove 2012 Remove DNA Remove Targeted Protein Degradation Related Topics
Small Molecule Pharma Companies Pharmacokinetics Immune Response RNA Clinical Research Pharmaceuticals Therapies Clinical Development Licensing More Related Topics >
article thumbnail

Where is the drug discovery expertise happening in the UK?

Drug Discovery World

OCTOBER 16, 2023

TrakCel based itself in the UK in 2012 because uniting the technology and life-sciences sectors requires a strong, diverse talent pool to draw from, which the UK offers. The UK, and specifically Wales, has been hugely supportive of life sciences and building a highly collaborative network.

Drugs 189
Drugs Science Therapies Targeted Protein Degradation 189
article thumbnail

Antibody-drug conjugates payloads: then, now and next

Drug Target Review

OCTOBER 4, 2023

2 In response, DNA-damaging agents that could target the entire cell cycle received renewed attention as ADC payloads. 9 Others, like psymberin, have been used as ADC payloads, with a β-glucuronide linker to target CD-30-positive and CD-70-positive malignancies. Florian S, Mitchison TJ. Anti-Microtubule Drugs. Chang, P. &

Small Molecule 126
Small Molecule Drugs Immune Response Targeted Protein Degradation 126
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 42,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024